Boston Scientific Corporation (BSX) vs Natera, Inc. (NTRA)
A side-by-side comparison of Boston Scientific Corporation and Natera, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
BSX
Boston Scientific Corporation
$42.60HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
NTRA
Natera, Inc.
$410.35HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — BSX vs NTRA
growth of $100 · dividends reinvested · last 10yBSX +85.7% (+6.4%/yr)NTRA +3613.4% (+43.5%/yr)NTRA compounded faster over this window
Log scale — wide-divergence pair
BSX NTRA
BSX vs NTRA: by the numbers
- •BSX is the larger company ($63.32B vs $58.77B market cap).
- •BSX is profitable (17.47% net margin) while NTRA runs a net loss (-7.11%).
- •NTRA grew revenue faster over the past five years (39.92% vs 13.40% CAGR).
Metrics side by side
Valuation
| Metric | BSX | NTRA |
|---|---|---|
| P/E ratio | 17.32 | N/A |
| Forward P/E | 13.03 | N/A |
| PEG ratio | 0.58 | N/A |
| P/S ratio | 3.02 | 21.71 |
| P/B ratio | 2.54 | 32.26 |
| EV / EBITDA | 13.01 | N/A |
| FCF yield | 5.72% | 0.12% |
Profitability
| Metric | BSX | NTRA |
|---|---|---|
| Gross margin | 71.16% | 65.30% |
| Operating margin | 21.46% | -10.70% |
| Net margin | 17.47% | -7.11% |
| ROE | 14.71% | -10.56% |
| ROIC | 10.57% | -13.26% |
Growth (annualized)
| Metric | BSX | NTRA |
|---|---|---|
| Revenue CAGR (5Y) | 13.40% | 39.92% |
| EPS CAGR (5Y) | 29.71% | N/A |
| FCF CAGR (5Y) | 15.64% | N/A |
| Total return CAGR (5Y) | 0.09% | 29.45% |
Frequently asked
- Which has grown faster, BSX or NTRA?
- Over the past five years, NTRA grew revenue faster — BSX at a 13.40% CAGR versus NTRA at 39.92%.
- Is BSX or NTRA more profitable?
- BSX runs the higher net margin — BSX at 17.47% versus NTRA at -7.11%.
- How have BSX and NTRA total returns compared?
- Over the past 10 years, BSX delivered 5.99% and NTRA delivered 43.39% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioBoston Scientific ROENatera ROEBoston Scientific operating marginNatera operating marginBoston Scientific revenue growthNatera revenue growthBoston Scientific free cash flowNatera free cash flow
Boston Scientific & Natera appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.